Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia

Acta Haematologica

Volumn 122, Issue 1, 2009, Pages 52-53

  Yamamoto, Yuko ^a   Sasaki, Makoto ^a   Oshimi, Kazuo ^a   Sugimoto, Koichi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CHIMERIC PROTEIN; CREATININE; DAUNORUBICIN; ENOCITABINE; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CASE REPORT; CHROMOSOME TRANSLOCATION; CONTINUOUS HEMODIAFILTRATION; CREATININE BLOOD LEVEL; DISSEMINATED INTRAVASCULAR CLOTTING; FUSION GENE; HEMODIALYSIS PATIENT; HUMAN; LETHARGY; MALE; MICROANGIOPATHY; NEUROIMAGING; PANCYTOPENIA; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; URINARY EXCRETION;

AGED; ARSENICALS; HUMANS; KIDNEY FAILURE, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; OXIDES; RENAL DIALYSIS;

EID: 70349793120     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243724     Document Type: Article

References (6)

1. Wang ZY, Chen Z: Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008; 111: 2505-2515.
2. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F: Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009; 113: 1875-1891.
3. Tallman MS: The expanding role of arsenic in acute promyelocytic leukemia. Semin Hematol 2008; 45:S25-S29.
4. Vaziri ND, Upham T, Barton CH: Hemodialysis clearance of arsenic. Clin Toxicol 1980; 17: 451-456.
5. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY: Use of arsenic trioxide (AS 2 O 3 ) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354-3360.
6. Fujisawa S, Ohno R, Shigeno K, Sahara N, Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y, Hashimoto H, Kinoshita K, Shimoya M, Kaise T, Ohnishi K: Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Cancer Chemother Pharmacol 2007; 59: 485-493.